In molecular biology and clinical research, Prostamax (also known as KEDP) is a synthetic tetrapeptide (a short chain of four amino acids). It belongs to the Khavinson peptide class, which acts as a cellular bioregulator.
Mechanism: It is studied for its ability to cause "decondensation" of tightly packed cellular DNA (chromatin). This potentially reactivates genes that have been silenced or suppressed due to cellular aging.
Research Areas: Preclinical trials focus on its ability to lower tissue inflammation, combat chronic aseptic prostatitis, and prevent tissue atrophy in prostate cells.
Availability: It is sold online as a freeze-dried, lyophilized powder (such as the vials found at Purepharmas.com
Regulatory Warning: These peptide formulations are strictly designated for laboratory research use only and are not approved for human consumption or general medical prescriptions.
